Prior efforts to identify regulators of hematopoietic stem cell physiology have relied mainly on candidate gene approaches with genetically modified mice. Here we used a genome-wide association study (GWAS) strategy with the hybrid mouse diversity panel to identify the genetic determinants of hematopoietic stem/progenitor cell (HSPC) frequency. Among 108 strains, we observed $120-to 300-fold variation in three HSPC populations. A GWAS analysis identified several loci that were significantly associated with HSPC frequency, including a locus on chromosome 5 harboring the homeodomain-only protein gene (Hopx). Hopx previously had been implicated in cardiac development but was not known to influence HSPC biology. Analysis of the HSPC pool in Hopx À/À mice demonstrated significantly reduced cell frequencies and impaired engraftment in competitive repopulation assays, thus providing functional validation of this positional candidate gene. These results demonstrate the power of GWAS in mice to identify genetic determinants of the hematopoietic system.
INTRODUCTION
In the hematopoietic stem cell (HSC) field, the identification of regulators of HSC physiology has relied mainly on candidate gene approaches with genetically modified mouse models (Rossi et al., 2012) . However, these studies have not necessarily provided a complete picture of the complex network of signals that govern HSC proliferation, differentiation, and function. Therefore non-biased strategies, such as transcriptome analyses, have been used, but these approaches also sometimes are restricted by the screen itself (Hope et al., 2010; Karlsson et al., 2013) . For example, many genes have been shown to be expressed at specific differentiation stages, including the most primitive HSCs (Chambers et al., 2007) , but they do not provide information as to the key regulators of HSC physiology.
An alternative unbiased strategy to elucidate the determinants of HSC frequency/function is to leverage naturally occurring variation in a forward genetics approach. In this regard, prior studies have shown that hematopoietic stem/progenitor cell (HSPC) frequency in mice differs as a function of genetic background , and attempts to identify the underlying genes have employed linkage analysis in crosses between inbred mouse strains. For example, using the long-term culture-initiating cell (LTC-IC; Müller-Sieburg and Riblet, 1996) or cobblestone area-forming cell (CAFC; de Haan and Van Zant, 1997) assays, quantitative trait loci (QTLs) for HSPC frequency have been identified on chromosomes 1 and 18 among a panel of recombinant inbred (RI) strains derived from C57Bl/6 3 DBA/2 (BXD). This strategy also has been used to map loci for dynamic changes in CAFC frequency associated with aging (de Haan and Van Zant, 1999; Geiger et al., 2001) . With the development of immunophenotypic markers that could identify functional HSPCs (Morrison and Weissman, 1994) , flow cytometric analysis has been used to identify QTLs for HSPC frequency in the BXD RI panel, but this approach has only been successful in aged mice (Henckaerts et al., 2002 (Henckaerts et al., , 2004 . In addition, QTLs for HSPCs distinct from those mapped in the BXD RI panel have been identified using different inbred mouse strains (Morrison et al., 2002; van Os et al., 2006; Jawad et al., 2008) , suggesting that the limited variation in crosses between two strains restricts the identification of other genetic factors that play a role in HSPC physiology. Furthermore, the classical QTL approach has inherently low mapping resolution, since the regions of interest typically span large chromosomal intervals and can contain hundreds to thousands of genes. To overcome these obstacles, a genetical genomics approach has been proposed, where transcriptomics analysis is combined with QTL mapping (de Haan et al., 2002; Bystrykh et al., 2005; Gerrits et al., 2008) . However, to date, the incorporation of intermediate molecular traits into linkage analysis has led to the identification of only one gene, latexin, where differential levels of expression influence the pool of HSPCs in the bone marrow (BM) (Liang et al., 2007) .
Genome-wide association studies (GWASs) represent another unbiased approach that has proven particularly successful in humans for gene discovery of numerous disease phenotypes (Hindorff et al., 2015) . Encouraged by this success, GWASs also have been proposed in mice using a recently developed panel of classic inbred and RI mouse strains, termed the Hybrid Mouse Diversity Panel (HMDP). Our prior studies with the HMDP have identified key associations for a variety of complex traits that are highly relevant to human diseases, which collectively illustrate the power of this approach for gene discovery in mice (Bennett et al., 2010 Farber et al., 2011; Ghazalpour et al., 2011 Ghazalpour et al., , 2012 Ghazalpour et al., , 2014 Park et al., 2011; Orozco et al., 2012; Davis et al., 2013; Parks et al., 2013; Hartiala et al., 2014) . In the present study, we used this mouse platform to carry out a comprehensive genetic screen for HSPC frequency in the adult BM. We identified multiple loci associated with the frequencies of three HSPC populations and functionally validated one positional candidate gene that previously had not been known to play a role in the hematopoietic system.
RESULTS

Variation in HSPC Frequencies in the HMDP
While the competitive repopulation assay is the gold standard for measuring HSPC frequency in a given population of cells (Purton and Scadden, 2007) , this method is influenced by a number of parameters, including radiation sensitivity of the host, homing and lodgment of the injected cells in the BM microenvironment, and differences in compensatory mechanisms involved in the differentiation of the mature hematopoietic cells. To limit variation due to any one or a combination of these parameters, we chose immunophenotypic analysis to characterize the frequency of primitive HSPC subsets in the adult BM. We obtained BM mononuclear cells (MNCs) from 12-weekold male mice (Table S1) (Kiel et al., 2008; Oguro et al., 2013) . In addition, we chose CD150 and CD48 for our analyses, since these Slam markers have been validated to identify the different sub-populations of HSPCs across multiple inbred mouse strains (Kiel et al., 2005) . Representative plots that illustrate the gating strategy used for these analyses are shown in Figure S1 . 
GWAS for HSPC Frequencies
To identify the genetic determinants of HSPC frequency, we used the phenotype data to carry out a GWAS for the three cell populations (Figures 2A-2C ). One significantly associated locus for LSKCD150 + CD48 À cells was identified at the distal end of chromosome 18 ( Figure 2A ; Table 1 ), where the lead SNP (rs36866074; p = 3.2 3 10 À6 ) mapped to intron 1 of the mitogen-activated protein kinase 4 (Mapk4) gene ( Figure 3A ). On chromosome 11 ( Figure 2A ; Table 1 ), we also identified suggestive association with an intergenic region located $464 kb downstream of the neuromedin-U receptor 2 (Nmur2) and $507 kb upstream of the glutamate receptor 1 isoform 1 precursor (Gria1) genes (rs29434264; p = 2.3 3 10 À5 ).
A GWAS for LSK cells revealed several suggestively associated loci, including those on chromosomes 2, 4, 6, and 18, ) and suggestive (p = 4.1 3 10 À4 ) evidence of association are indicated by the horizontal red and blue lines, respectively. See also Figure S3 .
as well as a highly significant (p = 3.7 3 10 À14 ) locus on chromosome 15 ( Figure 2B ; Table 1 ), where the lead SNP (rs31675052) is located approximately 100 kb downstream of Ly6f ( Figure 3B ). Ly6f is part of a family of genes located at this locus that encode Sca-1, which is one of the surface markers used to immunophenotypically quantitate HSPC frequency. While Sca-1 is known to play a role in the function of HSPCs (Ito et al., 2003) , some studies have suggested that it is not an informative cell surface marker for flow cytometry analysis in certain mouse strains (Spangrude and Brooks, 1993) . To address this potential issue and remove the effect of the chromosome 15 locus, we re-performed the GWAS analysis after excluding strains carrying the low Sca-1-expressing haplotype (Table S1 ). Importantly, exclusion of these strains did not appreciably decrease the heritability for variation in LSK cells (0.90 versus 0.82). Furthermore, the Sca-1 locus did not yield an association signal in this analysis, as expected, but the suggestive peak on chromosome 18 increased in significance from p = 4.3 3 10 À4 to just below the threshold for genome-wide significance with p = 9.4 3 10 À6 (Table 1 ; Figure S3A ).
The peak SNP (rs30267408) on chromosome 18 is not located within a known gene, but it maps $363 kb distal to the zinc-finger protein 521 (Zfp521) and $290 kb proximal to the synovial sarcoma-associated Ss18-alpha (Ss18) genes ( Figure S3B ). We next performed a GWAS for LSKCD150 À CD48 À cells and identified three significantly associated loci on chromosomes 1 (rs8242728; p = 9.3 3 10 À10 ), 5 (rs29633853; p = 5.1 3 10 À7 ), and 15 (rs32350275; p = 3.0 3 10 À7 ), as well as several suggestively associated loci on chromosomes 3, 11, 17, and 18 ( Figure 2C ; Table  1 ). Since the chromosome 15 locus for LSKCD150 À CD48
À cells was the same as that identified for LSKs, we reperformed the GWAS after excluding the same strains carrying the low Sca-1-expressing haplotype. Similar to LSK cells, excluding these strains only had a marginal effect on the heritability of LSKCD150 (Table 1 ; Figure S4A ). The lead SNP on chromosome 1 (rs8242728) fell within a large $2-Mb linkage disequilibrium (LD) block containing dozens of genes and numerous SNPs that yielded equivalently significant p values ( Figure 3C ). Given this LD pattern, it would be difficult to narrow down the underlying causative gene without extensive follow-up. For example, rs8242728 is specifically located within the NADH dehydrogenase [ubiquinone] iron-sulfur protein 2 (Ndufs2) gene. However, this interval also encompasses the Slam locus and contains the Cd48 and Slamf1 genes, which encode two of the other flow cytometry markers used for quantitating HSPCs (CD48 and CD150). By comparison, the most significantly associated SNPs on chromosome 5 are located within a small LD block, with the peak SNP (rs29633853) localizing to the homeodomain-only protein (Hopx) gene ( Figure 3D ). Interestingly, the suggestive association with the peak SNP on chromosome 18 (rs31073841), which maps $20 kb proximal to the peak SNP of the same Zfp521-Ss18 locus identified for LSKs, also increased in significance by nearly one order of magnitude from p = 3.8 3 10 À4 to p = 5.7 3 10 À5 after exclusion of the strains carrying the low Sca-1-expressing haplotype (Table 1 ; Figure S4A ). This observation suggests 
Frequency
Of the loci identified, we focused on the chromosome 5 locus because of the increased mapping resolution and the possibility that this region contains a previously unknown gene(s) for LSKCD150 À CD48 À cells. In particular, rs29633853 is located within intron 1 of Hopx, which has been shown to play important roles in cardiac development (Chen et al., 2002; Shin et al., 2002) and lymphoid regulation (Albrecht et al., 2010) and to serve as a marker for quiescent intestinal epithelial stem cells (Takeda et al., 2011) and multipotent hair follicle stem cells (Takeda et al., 2013) . However, Hopx has otherwise not been implicated in the biological regulation of HSPCs. To evaluate Hopx as a positional candidate, we first searched the publicly available genomic sequences of $60 inbred mouse strains, but we did not identify any amino acid substitutions and/or other protein structure-altering variations.
We next used gene expression data across multiple tissues in the HMDP (http://geneeqtl.genetics.ucla.edu/) to determine whether the chromosome 5 locus exhibited any cis expression QTL (eQTL), defined as those mapping within a 2-Mb interval centered on the lead GWAS SNP (rs29633853). Of the $20 genes in this region ( Figure 3D ), 
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À cells encompasses a large $2-Mb LD block containing dozens of genes and numerous SNPs that yielded equivalently significant p values. Although the lead SNP (rs8242728) is specifically located in Ndufs2 (boxed in red), this interval also includes Cd48 and Slamf1 (boxed in red), which encode two of other flow cytometry markers used for quantitating HSPCs (CD48 and CD150). Srd5a3, Tmem165, Exoc1, Cep135, and Hopx exhibited cis eQTLs in either bone, macrophages, liver, or heart (Table  2) . However, only variants in Hopx yielded both significant associations with LSKCD150 À CD48 À cells and cis eQTLs across all four tissues examined. In particular, the lead eQTL SNP in liver (rs33117479; p = 3.4 3 10 À18 ) was located $8 kb proximal to the lead SNP for LSKCD150 À CD48 À cells (rs29633853), whereas the lead eQTL SNP in heart (rs33175967; p = 6.2 3 10 À19 ) was $17 kb distal. The overlap between the association signals for LSKCD150 À CD48
À frequency and hepatic Hopx mRNA expression at the chromosome 5 locus is illustrated in Figure S4B . To further evaluate whether Hopx plays a role in the regulation of HSPCs, we performed gene expression analysis by RT-PCR in BM MNCs of 25 different mouse strains with varying LSKCD150
À CD48 À frequencies. These analyses demonstrated that Hopx was expressed in BM and that its mRNA levels were both variable and correlated (r = 0.44) with LSKCD150 À CD48 À frequency in these strains (Figure 4A ). This latter observation is not entirely surprising since the coincident mapping of cis eQTLs for Hopx across multiple tissues and LSKCD150 À CD48 À frequency to the same chromosome 5 could be expected to result in a correlation between Hopx gene expression and cell number in BM. We next purified various HSPC subsets and other hematopoietic-derived lineages from C57BL/6 mice and determined the cell-specific expression pattern of Hopx. These analyses revealed that Hopx was expressed in all hematopoietic cells and at particularly high levels in mature hematopoietic lineages, such as CD3 + T lymphocytes (Figure 4B ). To confirm these findings, we used flow cytometry to analyze BM of genetically modified mice that express GFP under the control of the endogenous Hopx promoter (Takeda et al., 2013) . As shown in Figure 4C , Figure 5B ). However, analysis of multi-lineage engraftment in these mice did not reveal significant differences in the relative abundance of circulating B lymphocytes, T lymphocytes, or myeloid cells ( Figure S5 À CD48 À population of HSPCs and especially abundant in CD3 + cells, consistent with the RT-PCR results. Fluorescence was quantitated by flow cytometry in different HSPC sub-populations and mature hematopoietic lineages in BM MNCs that were isolated from the femurs and tibias of 12-week-old genetically modified mice (n = 3) expressing GFP under the control of the endogenous Hopx promoter (Takeda et al., 2013) . Data are expressed in a.u. Note the different x axes in the plots.
( Figure 5D ). However, Hopx deficiency had no cell-cycle effects on LSKs ( Figure 5D ) or LSKCD150 + CD48 À cells (data not shown). Taken together, these data validate the GWAS findings and provide functional evidence that Hopx is a positive regulator of HSPC frequency in mice.
DISCUSSION
In the present study, we carried out a phenotypic screen with over 100 inbred strains from the HMDP to investigate how the frequency of three HSPC populations varies as a function of naturally occurring genetic variation. The results revealed substantial variability across this panel of mouse strains, at least based on the specific cell surface markers we used to quantify cell number. However, this may not necessarily reflect the true variation in the pool size of all stem cells, since, for example, the number of HSPCs in strains carrying the Sca-1 null allele could be underestimated. Despite this possibility, we still observed relatively strong correlations between certain HSPC subsets, but, interestingly, not between HSPCs and the number of circulating mature blood cells or other hematological parameters.
Using the strain survey data, we also carried out a GWAS analysis and identified multiple distinct and overlapping loci that were significantly or suggestively associated with HSPC sub-populations. At one particular locus on chromosome 5, we provide strong evidence that LSKCD150
À CD48 À cell frequency and function is À cells in particular, play distinct temporal roles in the maintenance of the hematopoietic system (Busch et al., 2015) . More specifically, it is the LSKCD150 À CD48 À sub-population of cells that sustains adult hematopoiesis under homeostatic conditions through multiple rounds of selfrenewal. Furthermore, proliferation of this cell population accounts for the differentiation of committed progenitors, while only receiving limited input from the more primitive LSKCD150 + CD48 À sub-population of cells.
Hopx is a homeodomain-only protein that lacks DNAbinding activity yet is predominantly localized to the nucleus (Chen et al., 2002; Shin et al., 2002) . There are many different functional roles proposed for this protein depending on the cell type examined. Through direct protein-protein interactions, Hopx was shown to repress the expression of serum response factor (SRF)-dependent genes (Kook and Epstein, 2003) , and conditional deletion of Srf in mouse BM leads to an approximate 3-fold increase in the frequency of all HSPC sub-populations (Ragu et al., 2010 Other groups have shown that Hopx promoter methylation frequently is observed in many malignancies, including esophageal, gastric, pancreatic, and colorectal cancers, where it has been suggested that Hopx functions as a tumor suppressor gene (Yamashita et al., 2013) . Since it is known that deficiency of a number of genes in the hematopoietic system leads to increased entry into cell cycle, with a consequent loss of HSPC frequency and function (Orford and Scadden, 2008) , it is possible that perturbation of Hopx expression/activity affects the intrinsic homeostasis of HSPCs by altering cellular quiescence and, thus, cell frequency. Two other interesting observations from our GWAS results were the overlap of loci that previously had been mapped for HSPC phenotypes using linkage analysis and identification of genomic regions that harbored genes encoding cell surface markers used for flow cytometry. In this regard, we identified a major locus for LSK cells over the genes encoding Sca-1 (Ly6e-Ly6a-Ly6f) on chromosome 15, which confirms previous reports that certain strains carry a Sca-1 haplotype associated with decreased expression (Spangrude and Brooks, 1993) . Exclusion of these strains from the analysis did not significantly decrease the heritability of LSK variation or reveal additional loci, but yielded highly suggestive evidence for association with a chromosome 18 locus containing Zfp521. QTL analysis with BXD RI strains also identified a locus for HSC frequency on chromosome 18 near Zfp521, although the peak of that linkage signal mapped $20 Mb distal from our lead GWAS SNP . Zfp521 encodes a transcription factor protein with 30 zinc fingers that was originally identified as being specifically expressed in primitive human CD34
+ cells compared to more mature hematopoietic cells (Bond et al., 2004) . More recently, Zfp521 also has been implicated in bone formation (Hesse et al., 2010; Kiviranta et al., 2013) , but validation of Zfp521 as a gene directly influencing HSPCs will require additional functional studies. Notably, the loci on chromosomes 15 (Ly6e-Ly6a-Ly6f) and 18 (Zfp521-Ss18) were identified in the GWAS analyses for LSKCD150 À CD48 À cells as well.
However, aside from these two regions, there was no overlap between the loci identified for the three HSPC populations or with those previously reported for blood cell traits in the HMDP (Davis et al., 2013) . In addition to Ly6e-Ly6e-Ly6f, our GWAS analysis revealed highly significant association of LSKCD150 À CD48 À cells with the Slam locus on chromosome 1, the strength of which increased by two orders of magnitude after excluding the low Sca-1-expressing strains. Consistent with our results, Müller-Sieburg and Riblet (1996) also mapped a QTL for HSCs directly over the Slam locus using the CAFC assay and linkage analysis in the BXD RI panel. Although we cannot determine with certainty whether Cd48 and Slamf1 account for the signal on chromosome 1 due to extensive LD across this region, Cd48-deficient mice do exhibit increased numbers of short-term HSCs (Boles et al., 2011) . While GWAS in humans has been successful in identifying genes for many different disease phenotypes, these types of analysis have had limited success for HSPCs. This is due, in part, to the logistical challenges of obtaining the relevant tissue in humans (i.e., BM) in large numbers of subjects in order to have sufficient mapping power. For example, a GWAS in the Framingham Heart Study for levels of circulating CD34 + cells only identified suggestive loci, none of which could be functionally validated (Cohen et al., 2013) . With respect to the present results, the relevance of the identified genes and pathways to humans is still to be determined. However, it is encouraging that recent studies in the HMDP were able to directly correlate mouse association signals with those identified in human GWAS (Davis et al., 2013; Parks et al., 2013) . For instance, four of the five loci identified for RBC parameters in the HMDP (Davis et al., 2013) correspond to loci recently reported for analogous phenotypes in a large human GWAS (van der Harst et al., 2012) . These observations reinforce the concept that the underlying biological pathways for complex traits are likely to be conserved between mice and humans.
In summary, we demonstrate the power of the HMDP as a platform to identify the genetic determinants of highly relevant biomedical traits that would otherwise not be feasible or logistically challenging to investigate in humans. While our studies only investigated the genetic determinants of HSPC frequency in the adult BM, they provide a proof of principle that similar unbiased approaches can be applied to comparable or more complex phenotypes in other stem cell systems. Such gene discovery efforts may lead to targets that could be studied toward further understanding the biological regulation of stem cells and/or manipulated for therapeutic development.
EXPERIMENTAL PROCEDURES
Animals
The 12-week-old male mice of 108 inbred strains (n = 3-8) from the HMDP were obtained (The Jackson Laboratory) and used in accordance with the USC Institutional Animal Care and Use Committee guidelines. Mice were maintained on a 12-hr light/dark cycle in sterilized microisolator cages and received autoclaved food and water ad libitum. Biological validation of Hopx was carried out using previously generated genetically targeted mice (Chen et al., 2002; Takeda et al., 2013) .
Flow Cytometry
BM MNCs were incubated in PBS with fluorescent labeled antimouse antibodies. The labeled cells were then analyzed by flow cytometry using an LSR II flow cytometer (Becton Dickinson), and HSPC frequencies were calculated according to established cell immunophenotypes using FlowJo flow cytometry analysis software. Figure S1 illustrates the gating strategy used for the flow cytometry analyses in selected mouse strains that were chosen to represent the range of variation in HSPC frequency. Details regarding the flow cytometric analyses are described in the Supplemental Experimental Procedures and a list of all antibodies used is given in Table S3 .
Complete Blood Count Analysis
Mice (n = 3/strain) were fasted for 4-5 hr and bled from the retro-orbital plexus under isoflurane anesthesia 2-3 hr after the beginning of the light cycle. Blood was collected in 20-ml EDTAcoated glass capillaries, processed using standard procedures, and profiled with respect to hematological parameters using the Heska HemaTrue Veterinary Hematology Analyzer, as described previously (Davis et al., 2013) .
Statistical Genetics Analysis
GWAS analyses utilized $880,000 genotyped and imputed SNPs and implemented an efficient mixed model algorithm (EMMA) that takes into account the underlying population structure and genetic relatedness across the strains, as described previously (Kang et al., 2008; Bennett et al., 2010) . Details regarding the statistical genetics methodology are described in the Supplemental Experimental Procedures.
Gene Expression Analysis
Total RNA was extracted using RNA Miniprep Kits (Stratagene) and was reverse-transcribed into cDNA using SuperScript VILO cDNA synthesis kits (Invitrogen). Taqman gene expression assay primers and probe sets (Applied Biosystems and Roche Diagnostics) were used to quantify expression of Hopx (assay ID Mm00558630_m1) and Hprt (assay ID Mm01545399_m1) as an endogenous control. Gene expression levels were measured in triplicate using a 7900HT real-time PCR system (Applied Biosystems). Standard curves in these experiments were created with the use of qPCR mouse reference total RNA (Stratagene). with 250,000 competitor BM MNCs from a B6.SJL congenic mouse, were injected into the tail veins of B6.SJL mice that were lethally irradiated with 9 Gy approximately 24 hr prior to transplantation. Peripheral blood samples were obtained from the tail vein of hosts starting at 4 weeks after transplantation and every 4 weeks thereafter, for a total of 24 weeks. PE anti-mouse CD45.1, fluorescein isothiocyanate (FITC) anti-mouse CD45.2, APC anti-mouse CD3e, APC-Cy7 anti-mouse CD11b, and biotinylated anti-mouse B220 antibodies (all from Becton Dickinson) were used to assess the degree of multi-lineage reconstitution.
Competitive Repopulation Assays
Cell-Cycle Experiments
For cell-cycle analysis, cells were incubated with 10 mg/ml Hoechst 33342 (Sigma-Aldrich) at 37 C for 45 min, then stained with lineage and stem cell antibodies as described above. The stained cells were resuspended and fixed in 10% buffered formalin and incubated at 4 C overnight. To stain for RNA content, pyronin Y (Polysciences) was added to the cells at a final concentration of 0.75 mg/ml and incubated at 4 C for 30 min. Cell-cycle status was examined using an LSR II flow cytometer (Becton Dickinson) and FlowJo software.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, five figures, and three tables and can be
